Autoimmune-mediated renal disease and hypertension

Area of Science:

• Nephrology
• Immunology
• Cardiovascular Medicine

Background:

• Hypertension is a significant risk factor for cardiovascular disease, chronic kidney disease (CKD), and mortality.
• Autoimmune renal diseases are frequently associated with hypertension, accelerating renal decline.
• Mechanisms linking inflammation and hypertension in autoimmune kidney diseases are poorly understood.

Purpose of the Study:

• To review the pathogenesis of major autoimmune kidney diseases associated with hypertension.
• To summarize current knowledge on hypertension in these conditions and their management.
• To identify research gaps and therapeutic targets for hypertension in autoimmune renal diseases.

Main Methods:

• Literature review of autoimmune renal diseases and hypertension.
• Focus on Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN), Immunoglobulin A (IgA) Nephropathy, Idiopathic Membranous Nephropathy (IMN), ANCA-associated glomerulonephritis, and Thrombotic Thrombocytopenic Purpura (TTP).
• Inclusion of disease-specific animal models exhibiting hypertension.

Main Results:

• Detailed overview of hypertension's role in specific autoimmune kidney diseases.
• Current management strategies for hypertension in these conditions are discussed.
• Identified understudied mechanisms and highlighted the need for further research.

Conclusions:

• Hypertension significantly impacts the progression of autoimmune kidney diseases.
• Further investigation into underlying mechanisms and novel therapeutic approaches is crucial.
• Animal models offer valuable insights for future research into hypertension in autoimmune renal diseases.